Initiating compression therapy for those living with heart failure
Dumitriu Saucedo1, Nicholas Evans2, Chung Sim Lim3
1Senior Clinical Fellow in Vascular Surgery, the Department of Vascular Surgery, Royal Free London NHS Foundation Trust.
British Journal of Community Nursing
|September 2, 2021
Summary
Compression therapy for leg swelling is safe for stable heart failure patients with precautions. Evidence is insufficient for severe heart failure, highlighting the need for clear guidelines.
Area of Science:
- Vascular Medicine
- Cardiology
- Clinical Practice Guidelines
Background:
- Chronic venous disease and lymphoedema frequently cause leg symptoms.
- Heart failure is common in patients with these leg conditions.
- Heart failure has traditionally contraindicated compression therapy.
Purpose of the Study:
- To evaluate the safety and effectiveness of compression therapy in heart failure patients.
- To recommend assessment and management strategies for initiating compression therapy in this population.
Main Methods:
- Systematic review of existing evidence on compression therapy in heart failure.
- Analysis of safety and effectiveness data.
- Development of recommendations based on current evidence.
Main Results:
- Compression therapy is safe for patients with stable, compensated heart failure when precautions are taken.
- Insufficient evidence exists regarding the safety of compression therapy for severe or decompensated heart failure.
- Standardized, evidence-based guidelines are needed.
Conclusions:
- Initiating compression therapy in stable heart failure patients is feasible with appropriate measures.
- Further research is required to establish safety in severe heart failure.
- Development of guidelines will aid healthcare professionals and improve patient consent.
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
59
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
59
01:30Heart Failure V: Medical Management
52
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
52
01:30Heart Failure VII: Nursing Interventions
194
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
194
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
581
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
581
01:27Heart Failure I: Introduction
157
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
157
01:30Cardiomyopathy II: Dilated Cardiomyopathy
83
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
83